Clinical trials
Scleroderma, Systemic trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 7 |
| Not yet recruiting | 3 |
| Unknown status | 3 |
| Enrolling by invitation | 2 |
| Terminated | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hacettepe University | 6 |
| Istanbul University | 4 |
| Pamukkale University | 3 |
| Actelion | 2 |
| Cukurova University | 2 |
| Antalya Training and Research Hospital | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Boehringer Ingelheim | 1 |
| Dokuz Eylul University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 32 |
| Scleroderma, Diffuse | 17 |
| Scleroderma, Localized | 3 |
| Arthritis | 1 |
| Autoimmune Diseases | 1 |
| Dyspnea | 1 |
| Fatigue | 1 |
| Fibromyalgia | 1 |
| Hypertension, Pulmonary | 1 |
| Immune System Diseases | 1 |
Trials
Showing 76 to 32 of 32. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.